Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2022-04-26 17:00:48
Celebrating World IP Day with a focus on youth and innovation
Geneva, 26 April 2022 – On World Intellectual Property (IP) Day, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) ...
Read More2022-04-13 12:45:21
COVID-19 vaccines and treatments output continues apace; as health systems and last mile hurdles remain collective stumbling blocks
To date, over 13 billion doses of COVID-19 vaccines have been produced and 11 billion ...
Read More2022-04-04 13:49:50
Largest pharmaceutical industry-backed collective venture fund tackling antimicrobial resistance announces first portfolio investments
April 4, 2022, Geneva – The international trade body representing the biopharmaceutical industry (IFPMA) today ...
Read More2022-02-25 07:30:32
Three priorities to urgently increase access to COVID-19 vaccines
Innovative biopharmaceutical companies are at the forefront of the global effort to develop and manufacture ...
Read More2022-02-01 13:00:37
Taking action on AMR: Largest life sciences sector coalition shows leadership in R&D, appropriate use and access to antibiotics and responsible manufacturing
1 February 2022 (Geneva) – Today the AMR Industry Alliance released its latest Progress Report, ...
Read More2021-12-16 11:41:08
11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation
A year since the first COVID-19 vaccine was administered, vaccine makers including biotechnology firms, developing ...
Read More2021-12-03 15:07:32
Global pharmaceutical industry leaders meet with UK Prime Minister to discuss leadership in global health and innovation
London, 3 December, 2021 – Yesterday, global leaders from the pharmaceutical industry met with the ...
Read More
Latest Statement
2022-05-10 16:56:42
Open Letter on ACT-A Therapeutics and Ongoing Roadblocks to Enhancing Access
A number of global health stakeholders are asserting that the supply of COVID-19 therapeutics is a challenge globally, and that ...
Read More2022-05-10 12:25:38
IFPMA statement on Quad’s Outcome Document on TRIPS
London, 3 December, 2021 – Yesterday, global leaders from the ...
Read More2022-04-13 14:44:10
Introductory remarks by Thomas Cueni at IFPMA media briefing on 13 April 2022
London, 3 December, 2021 – Yesterday, global leaders from the ...
Read More2022-04-13 08:24:02
IFPMA statement at public hearings regarding a new international instrument on pandemic preparedness and response
London, 3 December, 2021 – Yesterday, global leaders from the ...
Read More2022-04-12 01:00:56
IFPMA comment on draft guidance on value of new antibiotics as part of UK “subscription-type” payment model
London, 3 December, 2021 – Yesterday, global leaders from the ...
Read More2022-03-21 17:31:48
Joint Industry Statement on the War in Ukraine
London, 3 December, 2021 – Yesterday, global leaders from the ...
Read More2022-03-16 11:29:09
IFPMA statement on TRIPS discussion document
London, 3 December, 2021 – Yesterday, global leaders from the ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.
mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
News Release
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read MoreOur Blog
How do we improve clinical trials post-pandemic?
This article featured in the Media Planet Clinical Trials campaign, available online and disseminated in print with the New Scientist. The COVID-19 pandemic has taught us a lot and yet we can still keep learning. While the pandemic has impacted everyone globally in ways that could never have been imagined, it has provided a spark for further exploration into how clinical trials should be improved,...
Read More
Vaccines can help make a better life possible for everyone
Vaccines are one of the most effective and cost-efficient medical technologies ever developed. Except for clean water, nothing has had a larger effect on global health than vaccines, especially for children.[1] Before COVID-19, even if vaccines saved millions of lives every year, they had become a routine and unremarkable part of life. Their benefits are so embedded in our lives that it is easy to...
Read More
The power of innovation: Malaria’s gamechanger
This op-ed was originally published for Media Planet's Malaria and Neglected Tropical Diseases campaign on 25 April 2022. We must make up ground lost in the fight against malaria during the COVID-19 pandemic. Innovation in vaccines and treatment offer hope for solutions. From 2019 to 2020, there was a 12.4% increase in malaria deaths. Approximately two-thirds of these deaths were linked to COVID-19 disruptions, but pandemics...
Read MoreLatest Tweets
